^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

MA9060

i
Other names: MA9060
News
Trials
Company:
Moffitt Cancer Center
Drug class:
Autophagy inhibitor, ULK3 inhibitor
News
Trials